Family Medicine · Odessa, MO
NPI
1750349874
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
408 N 4th St Ste B
Odessa, MO, 64076
Phone (816) 633-1630
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
295 services
Medicare patients, 2024
154
Average age 75
Drug cost, 2024
$1.9M
22,906 prescriptions
Company payments, 2025
$1,121
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ram Chandra was code 99233 (hospital e&m - subsequent), 51 times for 27 patients. In total Ram Chandra billed 295 services in 17 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 51 | 27 | $84.68 | $4,319 |
| 99285 Emergency Department E&M | Facility | 48 | 44 | $124.30 | $5,966 |
| 99283 Emergency Department E&M | Facility | 45 | 44 | $52.28 | $2,353 |
| 99223 Hospital E&M - Initial | Facility | 37 | 32 | $126.52 | $4,681 |
| 99284 Emergency Department E&M | Facility | 34 | 32 | $89.64 | $3,048 |
| 99239 Hospital Discharge Management | Facility | 25 | 22 | $82.44 | $2,061 |
| 99282 Emergency Department E&M | Facility | 11 | 11 | $28.52 | $314 |
By year: 2022 $49K for 572 services; 2023 $37K for 403 services; 2024 $27K for 295 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ram Chandra prescribed most often to Medicare patients was Atorvastatin Calcium, with 943 prescriptions and refills. In total Ram Chandra wrote 22,906 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 943 | 1,496 | 154 | $7,532 |
| Levothyroxine Sodium Generic | 839 | 1,267 | 122 | $7,036 |
| Pantoprazole Sodium Generic | 509 | 771 | 88 | $4,690 |
| Omeprazole Generic | 493 | 759 | 81 | $6,063 |
| Gabapentin Generic | 482 | 676 | 81 | $7,367 |
| Potassium Chloride Generic | 467 | 577 | 73 | $13K |
| Amlodipine Besylate Generic | 437 | 627 | 81 | $2,818 |
| Lisinopril Generic | 425 | 686 | 76 | $2,886 |
| Metformin Hcl Generic | 405 | 707 | 67 | $3,062 |
| Furosemide Generic | 380 | 552 | 70 | $2,150 |
| Carvedilol Generic | 348 | 517 | 61 | $2,617 |
| Eliquis Apixaban | 342 | 350 | 33 | $130K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 311 | 311 | 106 | $5,195 |
| Tramadol Hcl Generic | 307 | 318 | 83 | $2,300 |
| Losartan Potassium Generic | 305 | 472 | 49 | $2,580 |
Brand drugs: 2,968 claims; generic drugs: 19,531 claims; opioid claims: 762.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ram Chandra $1,121 ($1,121 in general payments such as food, travel and fees) from 16 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $209.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 13 | $209 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 13 | $154 |
| Lilly USA, LLC LLY | 6 | $111 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $108 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $86.04 |
| Dexcom, Inc. DXCM | 3 | $81.43 |
| Axsome Therapeutics, Inc. AXSM | 4 | $68.41 |
| Amgen Inc. AMGN | 4 | $67.32 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $55.67 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $50.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.